Persistent hijacking of brain proteasomes in HIV-associated dementia

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 893-902

  Nguyen, Trung P ^a   Soukup, Vicki M ^a   Gelman, Benjamin B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BRAIN PROTEIN; IMMUNOPROTEASOME; LOW MOLECULAR WEIGHT PROTEIN 7; PROTEASOME; PROTEINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PA 28 ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BRAIN CELL; BRAIN TISSUE; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEATH; DEMENTIA; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NERVE CELL; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PERIKARYON; PLASMA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; SYNAPSE; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS LOAD;

EID: 76149101291     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090390     Document Type: Article

References (68)

1. McArthur JC, Brew BJ, Nath A: Neurological complications of HIV infection. Lancet Neurol 2005, 4:543-555
2. Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994
3. Williams KC, Hickey WF: Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002, 25:537-562
4. Budka H: Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991, 1:163-175
5. Wiley CA, Achim C: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994, 36:673-676
6. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T, Tanahashi N, Yoshimura T, Tanaka K, Ichihara A: Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem 1994, 115:257-269
7. Heink S, Ludwig D, Kloetzel PM, Kruger E: IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci USA 2005, 102:9241-9246
8. Raasi S, Schmidtke G, de Giuli R, Groettrup M: A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol 1999, 29:4030-4036
9. Glickman MH, Ciechanover A: The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002, 82:373-428
10. Kloetzel PM: Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 2004, 5:661-669
11. Kloetzel PM, Ossendorp F: Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 2004, 16:76-81
12. Bose S, Brooks P, Mason GG, Rivett AJ: Gamma-interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation. Biochem J 2001, 353:291-297
13. Gaczynska M, Rock KL, Goldberg AL: Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993, 365:264-267
14. Gaczynska M, Rock KL, Spies T, Goldberg AL: Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci USA 1994, 91:9213-9217
15. Tishon A, Lewicki H, Rall G, Von Herrath M, Oldstone MB: An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology 1995, 212:244-250
16. Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ: Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol 2006, 12:100-107
17. Kulkosky J, Bray S: HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication. Curr HIV Res 2006, 4:199-208
18. Hegde AN: Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog Neurobiol 2004, 73:311-357
19. Ehlers MD: Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 2003, 6:231-242
20. Keller JN, Hanni KB, Markesbery WR: Impaired proteasome function in Alzheimer's disease. J Neurochem 2000, 75:436-439
21. Keller JN, Gee J, Ding Q: The proteasome in brain aging. Ageing Res Rev 2002, 1:279-293
22. Ma J, Wollmann R, Lindquist S: Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002, 298:1781-1785
23. Tsuji T, Shimohama S: Protein degradation in Alzheimer's disease and aging of the brain. Prog Mol Subcell Biol 2002, 29:43-60
24. Chondrogianni N, Gonos ES: Proteasome dysfunction in mammalian aging: steps and factors involved. Exp Gerontol 2005, 40:931-938
25. Ciechanover A, Brundin P: The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 2003, 40:427-446
26. Ding Q, Dimayuga E, Markesbery WR, Keller JN: Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J 2006, 20:1055-1063
27. Layfield R, Cavey JR, Lowe J: Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders. Ageing Res Rev 2003, 2:343-356
28. Gelman BB, Schuenke K: Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol 2004, 10:98-108
29. Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ: The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 2001, 27:326-335
30. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK: Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 2004, 26:759-778
31. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA, Mellors JW, Coffin JM: New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2003, 41:4531-4536
32. Anderson SW, Damasio H, Jones RD, Tranel D: Wisconsin Card Sorting Test performance as a measure of frontal lobe damage. J Clin Exp Neuropsychol 1991, 13:909-922
33. Monchi O, Petrides M, Petre V, Worsley K, Dagher A: Wisconsin Card Immunoproteasomes in HIV-Infected Brains 901 Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 2001, 21:7733-7741
34. An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, Tavolato B, Scaravilli F: Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 1997, 56:1262-1268
35. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F: Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 1997, 42:34-40
36. Raja F, Sherriff FE, Morris CS, Bridges LR, Esiri MM: Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol 1997, 93:184-189
37. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M, Gray F: Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999, 25:123-133
38. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I: Dendritic injury is a pathological substrate for human immunodeficiency virusrelated cognitive disorders. HNRC Group the HIV Neurobehavioral Research Center. Ann Neurol 1997, 42:963-972
39. Gartner S: HIV infection and dementia. Science 2000, 287:602-604
40. + peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001, 7:528-541
41. Gelman BB, Soukup VM, Holzer CE, 3rd, Fabian RH, Schuenke KW, Keherly MJ, Richey FJ, Lahart CJ: Potential role for white matter lysosome expansion in HIV-associated dementia. J Acquir Immune Defic Syndr 2005, 39:422-425
42. Keller JN, Huang FF, Markesbery WR: Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 2000, 98:149-156
43. Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, Spazzafumo L, Chiappelli M, Licastro F, Sorbi S, Pession A, Ohm T, Grune T, Franceschi C: Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol Aging 2006, 27:54-66
44. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, Ferrer I, Avila J, Lucas JJ: Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci 2003, 23:11653-11661
45. Vikman KS, Owe-Larsson B, Brask J, Kristensson KS, Hill RH: Interferon-gamma-induced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures. Brain Res 2001, 896:18-29
46. Gelman BB, Spencer JA, Holzer CE, 3rd, Soukup VM: Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 2006, 1:410-420
47. Bellizzi MJ, Lu SM, Gelbard HA: Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. J Neuroimmune Pharmacol 2006, 1:20-31
48. Bingol B, Schuman EM: Synaptic protein degradation by the ubiquitin proteasome system. Curr Opin Neurobiol 2005, 15:536-541
49. Yi JJ, Ehlers MD: Ubiquitin and protein turnover in synapse function. Neuron 2005, 47:629-632
50. Eberwine J, Belt B, Kacharmina JE, Miyashiro K: Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem Res 2002, 27:1065-1077
51. Eisenberg M, Kobilo T, Berman DE, Dudai Y: Stability of retrieved memory: inverse correlation with trace dominance. Science 2003, 301:1102-1104
52. DiAntonio A, Haghighi AP, Portman SL, Lee JD, Amaranto AM, Goodman CS: Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 2001, 412:449-452
53. Chung KK, Dawson VL, Dawson TM: The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 2001, 24:S7-S14
54. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R: Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci USA 2000, 97:9902-9906
55. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, Fox HS: Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS One 2008, 3:e2906
56. Zhu Y, Vergote D, Pardo C, Noorbakhsh F, McArthur JC, Hollenberg MD, Overall CM, Power C: CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J 2009, 23:2928-2941
57. Yewdell JW: Immunoproteasomes: regulating the regulator. Proc Natl Acad Sci USA 2005, 102:9089-9090
58. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monaco JJ, Colbert RA: Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 1998, 187:97-104
59. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG, Koszinowski UH, Kloetzel PM: A role for the proteasome regulator PA28alpha in antigen presentation. Nature 1996, 381: 166-168
60. -/- mice. Science 1999, 286:2162-2165
61. Dubiel W, Pratt G, Ferrell K, Rechsteiner M: Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem 1992, 267: 22369-22377
62. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 1998, 67:425-479
63. Ma CP, Slaughter CA, DeMartino GN: Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem 1992, 267:10515-10523
64. Bose S, Stratford FL, Broadfoot KI, Mason GG, Rivett AJ: Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem J 2004, 378:177-184
65. Shapshak P, Duncan R, Minagar A, Rodriguez de la Vega P, Stewart RV, Goodkin K: Elevated expression of IFN-gamma in the HIV-1 infected brain. Front Biosci 2004, 9:1073-1081
66. Griffin DE: Cytokines in the brain during viral infection: clues to HIV-associated dementia. J Clin Invest 1997, 100:2948-2951
67. Achim CL, Morey MK, Wiley CA: Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients. Aids 1991, 5:535-541
68. Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS: Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 2004, 157:163-175